½ÃÀ庸°í¼­
»óǰÄÚµå
1776738

¼¼°èÀÇ ¿ø°Ý ÀÇ·á Ç÷§Æû ½ÃÀå ¿¹Ãø(-2032³â) : ÄÄÆ÷³ÍÆ®, Àü°³ ¸ðµå, ¸ð´Þ¸®Æ¼, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ, Áö¿ªº° ºÐ¼®

Telehealth Platforms Market Forecasts to 2032 - Global Analysis by Component (Software, Services and Hardware), Deployment Mode (Cloud-Based and On-Premises), Modality, Application, End User and Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ ¿ø°Ý ÀÇ·á Ç÷§Æû ½ÃÀåÀº 2025³â 430¾ï 5,000¸¸ ´Þ·¯¸¦ Â÷ÁöÇÏ°í ¿¹Ãø ±â°£ µ¿¾È CAGR 24.8%·Î ¼ºÀåÇÏ¿© 2032³â±îÁö 2,030¾ï 1,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¿ø°Ý ÀÇ·á Ç÷§ÆûÀº È­»ó ÅëÈ­, ¾Û ¹× ¿Â¶óÀÎ Æ÷ÅÐÀ» ÅëÇØ ȯÀÚ¿Í °Ç°­ °ü¸® Á¦°ø¾÷ü¸¦ ¿ø°ÝÀ¸·Î ¿¬°áÇÏ´Â µðÁöÅÐ ¼Ö·ç¼ÇÀÔ´Ï´Ù. ÀÌ Ç÷§ÆûÀº ÀÓ»ó ¿öÅ© Ç÷ο츦 °£¼ÒÈ­ÇÏ°í ´ë±â ½Ã°£À» ´ÜÃàÇÏ¸ç ¿À´Ã³¯ÀÇ ¿¬°á ¼¼°è¿¡¼­ °Ç°­ °ü¸®¸¦º¸´Ù ½±°Ô ¾×¼¼½ºÇϰí È¿À²ÀûÀ̸ç ȯÀÚ Ä£È­ÀûÀÔ´Ï´Ù.

¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é 2021³â ¸»±îÁö 70% ÀÌ»óÀÇ ±¹°¡°¡ ¿ø°ÝÀÇ·á ¹× ¿ø°ÝÀÇ·á ¼­ºñ½º¸¦ ±¹°¡ÀÇ COVID-19 ´ëÀÀÀÇ ÀϺηΠä¿ëÇß½À´Ï´Ù.

Æí¸®ÇÏ°í »ç¿ëÇϱ⠽¬¿î °ü¸®¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

¿ø°Ý ÀÇ·á´Â À̵¿ ½Ã°£À» Àý¾àÇÏ°í ´ë±â ½Ã°£À» ´ÜÃàÇÔÀ¸·Î½á Å« ÆíÀǼºÀ» Á¦°øÇÕ´Ï´Ù. À̰ÍÀº ¸¸¼º Áúȯ °ü¸®, ¿ø°ÝÁö¿¡¼­ Àü¹®ÀÇ¿¡°Ô Á¢±Ù, ½Ã°£ ¿Ü Áø·á¸¦ ¿ä±¸ÇÒ ¶§ ƯÈ÷ Áß¿äÇÕ´Ï´Ù. ȤÀº ÃæºÐÇÑ ¼­ºñ½º¸¦ ¹ÞÁö ¾ÊÀº Áö¿ªÀÇ »ç¶÷µé¿¡°Ô À־ÀÇ Á¢±Ù¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. ÀÌ·¯ÇÑ È¯ÀÚ Áß½ÉÀÇ ¿Âµð¸Çµå ÄÉ¾î ¸ðµ¨·ÎÀÇ ½ÃÇÁÆ®´Â Çコ ÄÉ¾î ½Ã½ºÅÛ³»ÀÇ ¸íÈ®ÇÏ°í ¿µ¼ÓÀûÀÎ ¿ä±¸¸¦ ÃæÁ·ÇÏ´Â °ÍÀ¸·Î, ½ÃÀåÀÇ È®´ë¿¡ Á÷°áÇÕ´Ï´Ù.

µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹× »çÀ̹ö º¸¾È¿¡ ´ëÇÑ ¿ì·Á

¿ø°Ý ÀÇ·á Ç÷§ÆûÀº ¸Å¿ì ±â¹Ð¼ºÀÌ ³ôÀº ȯÀÚÀÇ °Ç°­ Á¤º¸(PHI)¸¦ ´Ù·ç±â ¶§¹®¿¡ µ¥ÀÌÅÍ À¯Ãâ ¹× ·£¼¶¿þ¾î¿Í °°Àº »çÀ̹ö °ø°ÝÀÇ Ç¥ÀûÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¿ì·Á´Â ȯÀÚ¿Í ÀÇ·á Á¦°ø¾÷ü ¸ðµÎ¿¡°Ô ÁÖÀúÇÔÀ» ³º½À´Ï´Ù. ½É°¢ÇÑ Á¤º¸ À¯ÃâÀÌ ¹ß»ýÇÏ¸é ½Å·Ú°¡ Å©°Ô ¼Õ»óµÇ¾î µµÀÔÀÌ Áö¿¬µÇ°í ºñ¿ëÀÌ ¸¹ÀÌ µå´Â ¹ýÀû Á¶Ä¡°¡ ÃëÇØÁú ¼ö ÀÖÀ¸¸ç ½ÃÀå ¼ºÀåÀÇ Å« ¾ïÁ¦¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù.

»õ·Î¿î Àü¹® ºÐ¾ß ¹× ¼­ºñ½º ÁøÃâ

»õ·Î¿î Àü¹® ºÐ¾ß¿Í ¼­ºñ½º·ÎÀÇ È®ÀåÀº ¿ø°Ý ÀÇ·á Ç÷§Æû¿¡ ÀÖ¾î Å« ±âȸ°¡ µÇ°í ÀÖ½À´Ï´Ù. ¿ø°Ý ¸ð´ÏÅ͸µÀÇ Áøº¸¿¡ ÀÇÇØ ÇÁ·Î¹ÙÀÌ´õ´Â Àü¹®ÀûÀÎ »ó´ãÀ̳ª °è¼ÓÀûÀÎ Äɾ Á¦°øÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ´Ù¾çÈ­´Â ȯÀÚÀÇ °á°ú¸¦ Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó, Ç÷§Æû ÇÁ·Î¹ÙÀÌ´õ¿¡ »õ·Î¿î ¼öÀÔ¿øÀ» °¡Á®¿À°í, ¿ø°Ý ÀǷḦ Çö´ëÀÇ ÇコÄɾî Á¦°ø¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î¼­ ÀÚ¸®¸Å±èÇÕ´Ï´Ù.

'ÇÏÀÌÇÁ »çÀÌŬ'°ú ºñÇö½ÇÀûÀÎ ±â´ë

½É°¢ÇÑ À§ÇùÀº ¿ø°Ý ÀÇ·áÀÇ ´É·Â°ú Á÷Á¢ÀûÀÎ ¿µÇâÀ» µÑ·¯½Ñ °ú´ëÇÑ ±â´ë¿¡ ÀÇÇÑ ÀáÀçÀûÀÎ ¿µÇâÀÔ´Ï´Ù. ±×·¸Áö ¾ÊÀ¸¸é ±Þ¼ÓÇÑ µµÀÔ ´Ü°è¿¡¼­ÀÇ ³«°üÀû ¿¹ÃøÀº ½Ç¸ÁÀ¸·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ:

COVID-19ÀÇ ´ëÀ¯ÇàÀº ¿ø°Ý ÀÇ·á Ç÷§ÆûÀÇ Ã¤¿ëÀ» ±ØÀûÀ¸·Î °¡¼ÓÈ­Çß½À´Ï´Ù. ±ÔÁ¦ À庮ÀÌ ºü¸£°Ô ¿ÏÈ­µÇ°í, »óȯ Á¤Ã¥µµ ÀûÀÀµÇ¾î ¿ø°Ý ÀÇ·á ¼­ºñ½ºÀÇ ±Þ¼ÓÇÑ È®´ë°¡ °¡´ÉÇØÁ³À¸¸ç, ±× °á°ú ¿ø°Ý ÀÇ·áÀÇ ÀÌ¿ëÀÌ ±ÞÁõÇÏ¿© °Ç°­ °ü¸® Á¦°ø¿¡ ÇʼöÀûÀΠä³ÎÀÌ µÇ¾ú½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È Ŭ¶ó¿ìµå ±â¹Ý ºÎ¹®ÀÌ ÃÖ´ë°¡ µÉ Àü¸Á

¿¹Ãø ±â°£ µ¿¾È Ŭ¶ó¿ìµå ±â¹Ý ºÎ¹®ÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·± ÀÌÁ¡Àº Ŭ¶ó¿ìµå ¼Ö·ç¼ÇÀÌ Á¦°øÇÏ´Â È®À强, À¯¿¬¼º ¹× ºñ¿ë È¿°ú·Î ÀÎÇØ ±âÁ¸ ÀÇ·á ÀÎÇÁ¶ó¿ÍÀÇ ¿øÈ°ÇÑ ÅëÇÕÀ» ÃËÁøÇÕ´Ï´Ù. ¾ÈÀü¼ºÀ» ³ôÀÌ°í °­·ÂÇÑ º¸¾È ÇÁ·ÎÅäÄÝÀ» Áö¿øÇÏ¸ç ½Ç½Ã°£ ¾÷µ¥ÀÌÆ® ¹× ¿ø°Ý ¸ð´ÏÅ͸µÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ȯÀÚ(¼ÒºñÀÚ Á÷Á¢ ÆÇ¸Å ¸ðµ¨) ºÎ¹®ÀÇ CAGRÀÌ °¡Àå ³ôÀ» °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È, ȯÀÚ(¼ÒºñÀÚ Á÷Á¢ ÆÇ¸Å¸ðµ¨) ºÎ¹®Àº °¡Àå ³ôÀº ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ Æø¹ßÀûÀÎ ¼ºÀåÀÇ ¹è°æÀº ±ä±Þ ÀÇ·á, °æ¹ÌÇÑ Áúº´, ó¹æÀü º¸Ãæ, °Ç°­ »ó´ã µî ±ä±Þ¼ºÀÌ ¾ø´Â ¹®Á¦¿¡¼­µµ ½Å¼ÓÇÏ°Ô Æí¸®ÇÏ°Ô °Ç°­¿¡ Á¢±ÙÇϰíÀÚ ÇÏ´Â ¼ÒºñÀÚ ¿ä±¸ Áõ°¡°¡ ÀÖ½À´Ï´Ù. ȯÀÚ´Â ÀüÅëÀûÀÎ ÀÏÁ¤ Áö¿¬À» ÇÇÇϰí 24½Ã°£ 365ÀÏ ¾Û°ú À¥ Ç÷§ÆûÀ» ÅëÇØ Á÷Á¢ Ä¡·á¿¡ ¾×¼¼½ºÇÒ ¼ö ÀÖ´Â ´É·ÂÀ» Á¡Á¡ ´õ Áß½ÃÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ µðÁöÅÐ Çコ ¸®ÅÍ·¯½ÃÀÇ °íÁ¶¿Í DTC ¿ø°Ý ÀÇ·á ±Þ¿©ÀÇ °í¿ëÁÖ/º¸Çè»ç ä¿ëÀÌ ÀÌ µ¿ÇâÀ» °¡¼Ó½Ã۰í ÀÖ½À´Ï´Ù.

ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª:

¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ Áö¿ªÀÇ ¸®´õ½ÊÀº °ß°íÇÑ µðÁöÅÐ °Ç°­ ÀÎÇÁ¶ó, ¿ø°Ý ÀÇ·á ÀÌÀÍ¿¡ ´ëÇÑ ³ôÀº ÀÎÁöµµ, ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¸Àç¿¡ ÀÇÇØ Áö¿øµË´Ï´Ù. ¶ÇÇÑ ¸¸¼º ÁúȯÀÇ ¸¸¿¬, À¯¸®ÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©, °Ç°­ °ü¸® Çõ½Å¿¡ ´ëÇÑ °­·ÂÇÑ ÅõÀÚ´Â Áö¼ÓÀûÀÎ ¼ö¿ä¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ºÏ¹ÌÀÇ ¼º¼÷ÇÑ »óȯȯ°æ°ú °¡»ó ÄÉ¾î ¸ðµ¨ÀÇ Á¶±â µµÀÔÀº ¼¼°èÀÇ ¿ø°Ý ÀÇ·á Ç÷§Æû ½ÃÀå¿¡¼­ Áö¹èÀû ÁöÀ§¸¦ ´õ¿í °ß°íÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª:

¿¹Ãø ±â°£ µ¿¾È ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·¯ÇÑ ±Þ¼ºÀåÀº ¹æ´ëÇÑ Àα¸ ±â¹Ý, ÀÎÅÍ³Ý ¹× ½º¸¶Æ®Æù º¸±Þ·ü Áõ°¡, °Ç°­ °ü¸® ºñ¿ë »ó½Â, ƯÈ÷ ±¤´ëÇÑ ³óÃÌ Áö¿ª ¹× ¼­ºñ½º°¡ ¹ÌÄ¡Áö ¸øÇÑ Áö¿ª¿¡¼­ÀÇ ¾×¼¼½º¸¦ °³¼±Çϱâ À§ÇØ µðÁöÅÐ °Ç°­ µµÀÔÀ» ÃËÁøÇÏ´Â Á¤ºÎÀÇ Áß¿äÇÑ ÀÌ´Ï¼ÅÆ¼ºê¿¡ ÀÇÇØ ÃÊ·¡µË´Ï´Ù. °Ô´Ù°¡, ÀÇ·á °ü±¤ Áõ°¡, ¸¸¼º Áúȯ ºÎ´ã Áõ°¡, Æí¸®ÇÑ ÄÉ¾î ¼Ö·ç¼ÇÀ» ¿ä±¸ÇÏ´Â ÇÏÀÌÅ×Å©¿¡ Àͼ÷ÇÑ »ç¶÷µéÀÇ ÃâÇöÀº ÀÌ Áö¿ªÀÇ ´Ù¾çÇÑ ½ÃÀå¿¡¼­ ¿ø°Ý ÀÇ·á È®´ë¸¦ À§ÇÑ ºñ¿ÁÇÑ Åä¾çÀ» ¸¸µé¾î³»°í ÀÖ½À´Ï´Ù.

»ç¿ëÀÚ Á¤ÀÇ ¹«·á Á¦°ø:

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÑ °í°´Àº ´ÙÀ½ ¹«·á ¸ÂÃã¼³Á¤ ¿É¼Ç Áß Çϳª¸¦ ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù.

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀû ÇÁ·ÎÆÄÀϸµ(3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(3°³»ç±îÁö)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ ÀÀÇÑ ÁÖ¿ä±¹ ½ÃÀå Ãß°è, ¿¹Ãø ¹× CAGR(ÁÖ: Ÿ´ç¼º È®Àο¡ µû¸§)
  • °æÀï º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû Á¸Àç, Àü·«Àû Á¦ÈÞ¿¡ ±â¹ÝÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù
  • Á¶»ç ÀÚ·á
    • 1Â÷ Á¶»ç ÀÚ·á
    • 2Â÷ Á¶»ç Á¤º¸¿ø
    • ÀüÁ¦Á¶°Ç

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • ¿ëµµ ºÐ¼®
  • ÃÖÁ¾ »ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷°£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ ¿ø°Ý ÀÇ·á Ç÷§Æû ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

  • ¼­ºñ½º
    • ±¸Çö ¹× ÅëÇÕ ¼­ºñ½º
    • ±³À° ¹× ±³À° ¼­ºñ½º
    • ÄÁ¼³ÆÃ ¼­ºñ½º
    • À¯Áöº¸¼ö ¹× Áö¿ø ¼­ºñ½º
  • ¼ÒÇÁÆ®¿þ¾î
    • Ç÷§Æû ¼ÒÇÁÆ®¿þ¾î
    • ºÐ¼® ¹× º¸°í ¼ÒÇÁÆ®¿þ¾î
    • ȯÀÚ Âü¿© ¼ÒÇÁÆ®¿þ¾î
  • Çϵå¿þ¾î
    • ¿ø°Ý ÀÇ·á¿ë Ű¿À½ºÅ© ¹× īƮ
    • Á¢¼ÓÇü ÀÇ·á±â±â
    • ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ(RPM) ÀåÄ¡

Á¦6Àå ¼¼°èÀÇ ¿ø°Ý ÀÇ·á Ç÷§Æû ½ÃÀå : Àü°³ ¸ðµåº°

  • Ŭ¶ó¿ìµå ±â¹Ý
  • On-Premise

Á¦7Àå ¼¼°èÀÇ ¿ø°Ý ÀÇ·á Ç÷§Æû ½ÃÀå : ¸ð´Þ¸®Æ¼º°

  • ½Ç½Ã°£(µ¿±â)
  • ½ºÅä¾î ¾Ø Æ÷¿öµå(ºñµ¿±â)
  • ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ

Á¦8Àå ¼¼°èÀÇ ¿ø°Ý ÀÇ·á Ç÷§Æû ½ÃÀå : ¿ëµµº°

  • °¡»ó ÄÁ¼³Å×ÀÌ¼Ç ¹× ÀÓ»ó Äɾî
    • 1Â÷ ÄÉ¾î ¹× ÀÏ¹Ý Áø·á
    • Àü¹® Äɾî
    • ±ä±Þ ÄÉ¾î ¹× ÀÀ±Þ ¼­ºñ½º
  • ¸¸¼º Áúȯ °ü¸®
    • ´ç´¢º´ °ü¸®
    • °íÇ÷¾Ð °ü¸®
    • È£Èí±â Áúȯ °ü¸®
    • ½ÉÇ÷°ü Áúȯ °ü¸®
    • ¾à¹° »ç¿ë Àå¾Ö Ä¡·á
    • ±âŸ ¸¸¼ºÁúȯ °ü¸®
  • ¿¹¹æ ÄÉ¾î ¹× À£´Ï½º
    • °¡»ó Çコ ÄÚĪ
    • µðÁöÅÐ ¼¼¶óǻƽ½º
    • ¿ø°Ý ½ºÅ©¸®´× ¹× Æò°¡
  • ±Þ¼º±â ÈÄ ÄÉ¾î ¹× ÀçȰ
    • °¡»ó ¹°¸®Ä¡·á
    • ÀÛ¾÷¿ä¹ý
    • ¾ð¾î¿ä¹ý
    • ¼ö¼ú ÈÄ ÈļÓ
  • °ü¸® ¹× ¿î¿µ ¿ëµµ
    • ÀüÀÚ Ã³¹æ
    • ¼Ò°³ ¹× ÄɾîÀÇ Á¶Á¤
    • ½ºÄÉÁÙ ¹× û±¸
    • ȯÀÚÀÇ ¿Âº¸µù°ú °ü¸®

Á¦9Àå ¼¼°èÀÇ ¿ø°Ý ÀÇ·á Ç÷§Æû ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ÀÇ·á Á¦°øÀÚ
  • ȯÀÚ(¼ÒºñÀÚ Á÷Á¢ ÆÇ¸Å ¸ðµ¨)
  • ÁöºÒÀÚ(°øÀû ¹× ¹Î°£ °Ç°­ º¸Çè ȸ»ç)
  • Á¦¾à ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • ÀÇ·á±â±â ¹× ¼³ºñ Á¦Á¶¾÷ü
  • °í¿ëÁÖ´Üü ¹× Á¤ºÎ±â°ü

Á¦10Àå ¼¼°èÀÇ ¿ø°Ý ÀÇ·á Ç÷§Æû ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦11Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷, ÇÕÀÛÅõÀÚ
  • Àμö¿Í ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦12Àå ±â¾÷ ÇÁ·ÎÆÄÀϸµ

  • Teladoc Health, Inc.
  • Amwell(American Well Corporation)
  • MDLIVE, Inc.
  • Doctor On Demand, Inc.
  • Babylon Health Ltd.
  • HealthTap, Inc.
  • PlushCare, Inc.
  • Doxy.me Inc.
  • GlobalMed
  • MeMD, Inc.
  • SnapMD, Inc.
  • Siemens Healthineers AG
  • Koninklijke Philips NV
  • GE HealthCare Technologies Inc.
  • Medtronic plc
  • Oracle Health
  • Epic Systems Corporation
  • Cisco Systems, Inc.
JHS

According to Stratistics MRC, the Global Telehealth Platforms Market is accounted for $43.05 billion in 2025 and is expected to reach $203.01 billion by 2032 growing at a CAGR of 24.8% during the forecast period. Telehealth platforms are digital solutions that connect patients with healthcare providers remotely through video calls, apps, and online portals. They support virtual consultations, remote monitoring, and digital health records, improving access to care especially in rural or underserved areas. These platforms help streamline clinical workflows, reduce wait times, and make healthcare more accessible, efficient, and patient-friendly in today's connected world.

According to the World Health Organization (WHO), over 70% of countries adopted telemedicine or telehealth services as part of their national COVID-19 response by the end of 2021.

Market Dynamics:

Driver:

Increasing demand for convenient and accessible care

Telehealth offers significant convenience by eliminating travel and reducing wait times, which is particularly crucial for managing chronic conditions, accessing specialists remotely, or seeking after-hours care. It improves accessibility for populations in rural or underserved areas facing provider shortages. This shift towards patient-centric, on-demand care models directly fuels market expansion by meeting a clear and persistent need within the healthcare system.

Restraint:

Data privacy and cybersecurity concerns

Telehealth platforms handle highly sensitive patient health information (PHI), making them prime targets for cyberattacks like data breaches and ransomware. Concerns about unauthorized access, data leaks, and compliance with regulations create hesitancy among both patients and healthcare providers. A significant breach could severely damage trust, slow adoption, and lead to costly legal repercussions, acting as a major restraint on market growth.

Opportunity:

Expansion into new specialties and services

Expansion into new specialties and services presents a substantial opportunity for telehealth platforms. As technology evolves, platforms are increasingly able to support diverse medical fields, including mental health, dermatology, and chronic disease management. Furthermore, advancements in AI-driven diagnostics and remote monitoring enable providers to offer specialized consultations and continuous care. This diversification not only enhances patient outcomes but also opens new revenue streams for platform providers, positioning telehealth as an integral component of modern healthcare delivery.

Threat:

"Hype Cycle" and unrealistic expectations

A significant threat involves the potential fallout from inflated expectations surrounding telehealth's capabilities and immediate impact. Overly optimistic projections during rapid adoption phases could lead to disappointment if platforms fail to deliver seamless integration, consistent quality of care matching in-person visits, or demonstrable cost savings quickly enough. This "hype cycle" effect might result in reduced funding, slower provider uptake, or patient attrition if the technology is perceived as under-delivering on its initial promise.

Covid-19 Impact:

The Covid-19 pandemic dramatically accelerated the adoption of telehealth platforms. Social distancing measures, lockdowns, and the need to minimize virus transmission compelled both providers and patients to embrace virtual care. Regulatory barriers were swiftly relaxed, and reimbursement policies were adapted, enabling rapid scaling of telehealth services. As a result, telehealth usage surged, becoming a vital channel for healthcare delivery. This shift has had a lasting impact, embedding telehealth more deeply into healthcare systems and changing patient and provider expectations for the long term.

The cloud-based segment is expected to be the largest during the forecast period

The cloud-based segment is expected to account for the largest market share during the forecast period. This dominance is attributed to the scalability, flexibility, and cost-effectiveness offered by cloud solutions, which facilitate seamless integration with existing healthcare infrastructure. Additionally, cloud-based platforms enhance data accessibility for both providers and patients, support robust security protocols, and enable real-time updates and remote monitoring. As healthcare organizations increasingly prioritize digital transformation, the adoption of cloud-based telehealth solutions is set to remain strong, reinforcing their leadership in the market.

The patients (direct-to-consumer models) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the patients (direct-to-consumer models) segment is predicted to witness the highest growth rate. This explosive growth is fueled by increasing consumer demand for immediate, convenient access to healthcare for non-emergent issues like urgent care, minor illnesses, prescription refills, and wellness consultations. Patients increasingly value the ability to bypass traditional scheduling delays and access care directly via apps or web platforms 24/7. Moreover, growing digital health literacy and employer/insurer adoption of DTC telehealth benefits are accelerating this trend.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share. The region's leadership is underpinned by a robust digital health infrastructure, high awareness of telehealth benefits, and the presence of leading market players. Additionally, the prevalence of chronic diseases, favorable regulatory frameworks, and strong investment in healthcare innovation contribute to sustained demand. North America's mature reimbursement environment and early adoption of virtual care models further solidify its dominant position in the global telehealth platforms market.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. This rapid growth is driven by a massive population base, increasing internet and smartphone penetration, rising healthcare costs, and significant government initiatives promoting digital health adoption to improve access, especially in vast rural and underserved areas. Furthermore, growing medical tourism, increasing chronic disease burdens, and the emergence of tech-savvy populations seeking convenient care solutions create fertile ground for telehealth expansion across diverse markets in the region.

Key players in the market

Some of the key players in Telehealth Platforms Market include Teladoc Health, Inc., Amwell (American Well Corporation), MDLIVE, Inc., Doctor On Demand, Inc., Babylon Health Ltd., HealthTap, Inc., PlushCare, Inc., Doxy.me Inc., GlobalMed, MeMD, Inc., SnapMD, Inc., Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Medtronic plc, Oracle Health, Epic Systems Corporation and Cisco Systems, Inc.

Key Developments:

In April 2025, Teladoc Health the global leader in virtual care announced it has acquired UpLift, an innovative and tech-enabled provider of virtual mental health therapy, psychiatry and medication management services.

In March 2025, Doxy.me launched a refreshed platform with new features such as adaptive video, enhanced group calls, teleconsent, and expanded file transfer capabilities.

In January 2025, Amwell(R) a leader in digital care announced that Vida Health, a leader in virtual cardiometabolic care, is now part of the clinical programs portfolio on the Amwell platform.

Components Covered:

  • Services
  • Software
  • Hardware

Deployment Modes:

  • Cloud-Based
  • On-Premises

Modalities Covered:

  • Real-Time (Synchronous)
  • Store-and-Forward (Asynchronous)
  • Remote Patient Monitoring

Applications Covered:

  • Virtual Consultations & Clinical Care
  • Chronic Disease Management
  • Preventive Care & Wellness
  • Post-Acute Care & Rehabilitation
  • Administrative & Operational Applications

End Users Covered:

  • Healthcare Providers
  • Patients (Direct-to-Consumer Models)
  • Payers (Public & Private Health Insurers)
  • Pharmaceutical & Biotechnology Companies
  • Medical Device & Equipment Manufacturers
  • Employer Groups & Government Bodies

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Telehealth Platforms Market, By Component

  • 5.1 Introduction
  • 5.2 Services
    • 5.2.1 Implementation & Integration Services
    • 5.2.2 Training & Education Services
    • 5.2.3 Consulting Services
    • 5.2.4 Maintenance & Support Services
  • 5.3 Software
    • 5.3.1 Platform Software
    • 5.3.2 Analytics & Reporting Software
    • 5.3.3 Patient Engagement Software
  • 5.4 Hardware
    • 5.4.1 Telehealth Kiosks & Carts
    • 5.4.2 Connected Medical Devices
    • 5.4.3 Remote Patient Monitoring (RPM) Devices

6 Global Telehealth Platforms Market, By Deployment Mode

  • 6.1 Introduction
  • 6.2 Cloud-Based
  • 6.3 On-Premises

7 Global Telehealth Platforms Market, By Modality

  • 7.1 Introduction
  • 7.2 Real-Time (Synchronous)
  • 7.3 Store-and-Forward (Asynchronous)
  • 7.4 Remote Patient Monitoring

8 Global Telehealth Platforms Market, By Application

  • 8.1 Introduction
  • 8.2 Virtual Consultations & Clinical Care
    • 8.2.1 Primary Care & General Consultations
    • 8.2.2 Specialty Care
    • 8.2.3 Urgent Care & Emergency Services
  • 8.3 Chronic Disease Management
    • 8.3.1 Diabetes Management
    • 8.3.2 Hypertension Management
    • 8.3.3 Respiratory Disorders Management
    • 8.3.4 Cardiovascular Disease Management
    • 8.3.5 Substance Use Disorders Treatment
    • 8.3.6 Other Chronic Condition Management
  • 8.4 Preventive Care & Wellness
    • 8.4.1 Virtual Health Coaching
    • 8.4.2 Digital Therapeutics
    • 8.4.3 Remote Screenings & Assessments
  • 8.5 Post-Acute Care & Rehabilitation
    • 8.5.1 Virtual Physical Therapy
    • 8.5.2 Occupational Therapy
    • 8.5.3 Speech Therapy
    • 8.5.4 Post-Surgical Follow-up
  • 8.6 Administrative & Operational Applications
    • 8.6.1 E-Prescribing
    • 8.6.2 Referrals & Care Coordination
    • 8.6.3 Scheduling & Billing
    • 8.6.4 Patient Onboarding & Management

9 Global Telehealth Platforms Market, By End User

  • 9.1 Introduction
  • 9.2 Healthcare Providers
  • 9.3 Patients (Direct-to-Consumer Models)
  • 9.4 Payers (Public & Private Health Insurers)
  • 9.5 Pharmaceutical & Biotechnology Companies
  • 9.6 Medical Device & Equipment Manufacturers
  • 9.7 Employer Groups & Government Bodies

10 Global Telehealth Platforms Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Teladoc Health, Inc.
  • 12.2 Amwell (American Well Corporation)
  • 12.3 MDLIVE, Inc.
  • 12.4 Doctor On Demand, Inc.
  • 12.5 Babylon Health Ltd.
  • 12.6 HealthTap, Inc.
  • 12.7 PlushCare, Inc.
  • 12.8 Doxy.me Inc.
  • 12.9 GlobalMed
  • 12.10 MeMD, Inc.
  • 12.11 SnapMD, Inc.
  • 12.12 Siemens Healthineers AG
  • 12.13 Koninklijke Philips N.V.
  • 12.14 GE HealthCare Technologies Inc.
  • 12.15 Medtronic plc
  • 12.16 Oracle Health
  • 12.17 Epic Systems Corporation
  • 12.18 Cisco Systems, Inc.
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦